J&J suffers a loss over 340B drug discount program

J&J suffers a loss over 340B drug discount program

J&J argued the ruling contradicts the statute and allows for the continuing abuse and potential fraud that undermines the 340B program.

Judge rules against J&J, for HHS and 340B hospitals in rebate model case

A U.S. District Court for the District of Columbia judge June 27 ruled against Johnson & Johnson and sided with the Department of Health and Human Services and hospitals in a lawsuit brought by J&J challenging the government’s authority to reject J&J’s proposed 340B rebate model. “In sum, based on the plain and unambiguous language of the 340B statute, and supported by its purpose and history, HRSA has the authority to ‘provide’ for discounts, r…

Federal Judge Dismisses J&J’s Lawsuit, Rules HHS Must Preapprove 340B Rebate Models - 340B Report

A federal district judge today upheld the Department of Health and Human Services’ (HHS) authority to preapprove 340B rebate models, [...] The post Federal Judge Dismisses J&J’s Lawsuit, Rules HHS Must Preapprove 340B Rebate Models appeared first on 340B Report.

J&J dealt blow in fight over its 340B rebate model

A federal judge said the government did not run afoul of the law when it required Johnson & Johnson to seek approval before implementing its proposed 340B rebate model. The Friday decision marks another court ...